Maria Flynn is the Founder and CEO of Ambiologix, a consulting and training company that helps entrepreneurs advance their innovation, grow their potential, and build their businesses. Leveraging experience as an entrepreneur, executive, engineer, investor, and coach, Flynn works with select high-growth leaders, companies, investors, and entrepreneurial support organizations, helping them Make Opportunity Happen, which is the title of her book, keynote, and workshops.

As CEO of Orbis Biosciences, Flynn built a technology company that improved pharmaceutical manufacturing, won awards for its novel innovation, and was acquired by Adare Pharmaceuticals. As Managing Director of Techstars Kansas City, Flynn invested in and coached companies across health tech, biotech, fintech, deep tech, and consumer tech. As a business growth guide through her company Ambiologix, she has worked with founders from over 40 companies.

Flynn was a Director at Cerner Corporation, where she held P&L responsibility for a life sciences business unit that provided drug safety software and services to pharmaceutical companies. She also created a new enterprise within Cerner for regional healthcare software.

Flynn was named one of Entrepreneur Magazine’s Entrepreneurial Women to Watch and received the Pipeline Entrepreneurs’ Inspiration Award and Central Exchange’s STEMMy Enterprising Innovator Award. Flynn is the Founder and Chair of the Advisory Board of Digital Health KC and serves on the Board of Directors of BioNexus KC. Flynn earned degrees from the University of Chicago, Stanford University, and Kansas State University.

Business, Technology, Business Leadership, Science, Social Sciences, Scientists, Science and Technology Professionals, Environmental Science, Startup, Start-Up Founder, Food & Beverage, Consumer Goods, Consumer Behavior, Pharmaceutical, Product Development, Productivity, Chemical Engineering, Chemists, Integrative Biology, Biotechnology, Empowerment, Women in Business, Female Leadership, CEO, Leadership, Consulting, Entrepreneurship, Biology Forbes,